ALB and breast cancer: There was a statistically significant difference between the two patient groups; IGM patients had higher levels of fibrinogen (> 345.0 mg/dL), fibrinogen/albumin (Fib/Alb) ratio (> 82.79), CRP (> 3.625 mg/L), and NLR (> 2.285) compared to BC patients, demonstrating strong potential as practical guides for differentiating BC from IGM [102].